Results 251 to 260 of about 123,173 (290)

Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and ...
Robin Lengton   +4 more
wiley   +1 more source

The evolving landscape of cardiometabolic diseases. [PDF]

open access: yesEBioMedicine
Eroglu T, Capone F, Schiattarella GG.
europepmc   +1 more source

Prevalence and outcomes of DKA in type 1 and type 2 DM patients treated and not treated with SGLT‐2 inhibitors

open access: yesDiabetic Medicine, EarlyView.
Abstract Aim To compare the clinical characteristics, biochemical presentation, and short‐ and long‐term outcomes of DKA in hospitalized adults with T1DM and T2DM, including the impact of SGLT2 inhibitor therapy. Methods A retrospective cohort of 2283 adults (838 with T1DM; 1445 with T2DM) hospitalized with DKA between 2013 and 2023 across Clalit ...
Elena Chertok Shacham   +3 more
wiley   +1 more source

Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review. [PDF]

open access: yesWorld J Gastroenterol
Dutt K   +4 more
europepmc   +1 more source

‘There is more to life than HbA1c’: A comprehensive qualitative framework from the Hypo‐RESOLVE project evidencing the impacts of hypoglycaemia on the quality of life of adults living with type 1 or type 2 diabetes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims To develop a comprehensive, in‐depth understanding of the impacts of hypoglycaemia on the quality of life of adults living with type 1 (T1D) or type 2 diabetes (T2D). Methods Thirty‐one adults with T1D or T2D who experienced hypoglycaemia participated in semi‐structured interviews.
Philip A. Powell   +12 more
wiley   +1 more source

Targeting inflammation in cardiometabolic disease: Icosapent ethyl modulates monocyte‐derived macrophages isolated from patients with cardiovascular disease with or without type 2 diabetes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Despite intensive lipid‐lowering therapy, individuals with atherosclerotic cardiovascular disease (ASCVD) exhibit residual inflammatory risk, which drives recurrent cardiovascular events. This risk is amplified in type 2 diabetes mellitus (T2DM), where a pro‐inflammatory milieu accelerates atherogenesis. Monocyte‐derived macrophages (MDMs)
J. K. Ward   +4 more
wiley   +1 more source

Plant and Animal-Based Dietary Patterns and Cardiometabolic Diseases in the Brazilian Population: Cross-Sectional Analysis of the Brazilian National Health Survey. [PDF]

open access: yesNutrients
Correia PE   +13 more
europepmc   +1 more source

Change in body mass index and disease burden among people with obesity and multiple long‐term conditions

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Obesity is a risk factor for multiple long‐term conditions (MLTCs/multimorbidity). However, the impact of weight loss in people with MLTCs is unclear. We investigated the association between body mass index (BMI) change and the development of obesity‐related complications (ORCs), as well as clinical and economic outcomes in individuals ...
Kamlesh Khunti   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy